We report on a case of malignant basal cell carcinoma of the prostate combined with a poorly differentiated conventional adenocarcinoma, infiltrating bilaterally the seminal vesicles and with lymph-node and distant metastases. Basal cell carcinoma represented the prevalent component of the tumour (80%), showed high mitotic activity, extensive perineural infiltration and vascular invasion and was immunoreactive for basal cell related antigens (high molecular weight cytokeratins 34βE12 and p63). Our data confirm previous observations that basal cell carcinoma represents an aggressive tumour with an adverse clinical outcome
Metastases of basal cell carcinoma (BCC) are extrordinarily rare events, with only about 200 publish...
Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%),...
Milena Taskovska,1 Maja Frelih,2 Tomaž Smrkolj,1 Metka Volavšek2 1Chair of Surgery, Faculty o...
Abstract Background Basal cell carcinoma of the prostate is a relatively rare entity. Their evolutio...
The basal cell carcinoma of the prostate is a rare tumor. It usually presents as an obstruction to u...
Basal cell carcinoma of the prostate (BCP) is a neoplasm composed of prostatic basal cells. There ar...
Prostate basal cell carcinoma (PBCC) accounts for 0.01% of all prostate cancers. A 68-year-old man c...
Basal cell carcinoma (BCC) is a rare nonacinar variant of prostatic carcinoma. In spite of prostatic...
Introduction Basal cell carcinoma of the prostate is rare, with no established treatment for its rec...
Primary prostatic duct adenocarcinoma, initially labeled as endometrioid carcinoma of the prostate, ...
The relationship between the cells that initiate cancer and the cancer stem-like cells that propagat...
The 2004 WHO classification of lung tumours recognised basaloid carcinoma as a variant of squamous a...
Basal cell carcinoma is the most common human neoplasm, with hundreds of thousands of new cases occu...
Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers. Its metastasis is extre...
Basal cell carcinoma (also referred to as adenoid cystic carcinoma) is a rare tumor of the prostate....
Metastases of basal cell carcinoma (BCC) are extrordinarily rare events, with only about 200 publish...
Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%),...
Milena Taskovska,1 Maja Frelih,2 Tomaž Smrkolj,1 Metka Volavšek2 1Chair of Surgery, Faculty o...
Abstract Background Basal cell carcinoma of the prostate is a relatively rare entity. Their evolutio...
The basal cell carcinoma of the prostate is a rare tumor. It usually presents as an obstruction to u...
Basal cell carcinoma of the prostate (BCP) is a neoplasm composed of prostatic basal cells. There ar...
Prostate basal cell carcinoma (PBCC) accounts for 0.01% of all prostate cancers. A 68-year-old man c...
Basal cell carcinoma (BCC) is a rare nonacinar variant of prostatic carcinoma. In spite of prostatic...
Introduction Basal cell carcinoma of the prostate is rare, with no established treatment for its rec...
Primary prostatic duct adenocarcinoma, initially labeled as endometrioid carcinoma of the prostate, ...
The relationship between the cells that initiate cancer and the cancer stem-like cells that propagat...
The 2004 WHO classification of lung tumours recognised basaloid carcinoma as a variant of squamous a...
Basal cell carcinoma is the most common human neoplasm, with hundreds of thousands of new cases occu...
Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers. Its metastasis is extre...
Basal cell carcinoma (also referred to as adenoid cystic carcinoma) is a rare tumor of the prostate....
Metastases of basal cell carcinoma (BCC) are extrordinarily rare events, with only about 200 publish...
Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%),...
Milena Taskovska,1 Maja Frelih,2 Tomaž Smrkolj,1 Metka Volavšek2 1Chair of Surgery, Faculty o...